Improving Outcomes in Hereditary Gastrointestinal Polyposis Syndromes in the Mediterranean Region Thomas M Attard MD FAAP FACG Associate Professor, Pediatrics,

Slides:



Advertisements
Similar presentations
Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for.
Advertisements

Hereditary aspects of upper GI malignancy Eamonn Sheridan Consultant in Clinical Genetics.
Hereditary GI Cancer-a Primer for Medical Oncologists
MAMA - Network Project WP 7. MAMA-AWARE Coordinated by UNEP/MAP (MB 11) – MED POL Unit.
Hereditary GI Cancer Syndromes: Keys to identify high risk patients
COLON CANCER: CURRENT SURGICAL MANAGEMENT OPTIONS. ANTHONY D.I. SIBIYA, MD., GABORONE PRIVATE HOSPITAL.
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
USPSTF Screening Recommendations: Implications for Adults at Higher Risk NYFAHC Roundtable, June 18, 2013 Robert A. Smith, PhD Senior Director, Cancer.
Polyposis Syndromes of the Colon Current Management, Controversies and Future Direction Eric J. Dozois, MD Division of Colon & Rectal Surgery Mayo Clinic.
Prof. Dr. Giuseppe Magazzu Prof. Dr. Dušanka Mičetić-Turk and all Progress of the Prospective study - Medicel.
Celiac Disease in Malta Thomas M Attard MD FAAP FACG.
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
Hereditary Colon Cancer ACP, October 2013 Steve Lanspa MD, FACP.
Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.
Mechanisms and Epidemiology of Colon Cancer
Hereditary Colorectal Cancer: An Overview Felice Schnoll-Sussman,MD Jay Monahan Center for Gastrointestinal Health New York Hospital/ Weill Cornell Medical.
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Comprehensive IHC Screening for Lynch Syndrome: What You Need to Know Andrea Lewis, MS, CGC January 14, 2010.
Morning Report May 20, 2009 Bridger Clarke  Born in Lawrence, Massachusetts, on 4 January  Dropped out of high school at the age of fourteen.
SURVIVORS TEACHING STUDENTS: SAVING WOMEN’S LIVES®
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Issues in Genetic Testing: Real versus Not-so-Real Roberta A Pagon, MD Principal Investigator, GeneTests Professor, Pediatrics University of Washington.
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
Joint Hospital Surgical Grand Round 19 June 2004.
Update on Colon Cancer Screening and Prevention
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Genetics & Colorectal Cancer
Genetics of Colorectal Cancer
David A H Whiteman MD FAAP FACMG Global Clinical Sciences Leader Shire Pharmaceuticals.
Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas NICE CG March 2011.
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Colonoscopy; Surveillance Indications
Cancer in Our Genes International Patient Database A patient-driven database dedicated to finding a cure for VHL and other cancers.
Colorectal carcinoma Dr.Mohammadzadeh.
SNDA : CELEBREX TM INDICATION Reduction and Regression of Adenomatous Colorectal Polyps in Familial Adenomatous Polyposis Patients FDA ODAC Presentation.
Implementing universal Lynch Syndrome screening in a large healthcare system.
NICE guidelines: Management of dyspepsia in adults in primary care
The Mediterranean Pediatric FGIDs Project Dr. Elena Scarpato M.D. “Federico II” University of Naples.
Impact of the new ESPGHAN diagnostic criteria for celiac disease in the Mediterranean area The Mediterranean Network for Celiac Disease V Progress Meeting.
Universal Screening for Lynch Syndrome with Cascade Screening for Relatives September 7, 2012 Deb Duquette, MS, CGC Michigan Department of Community Health.
Familial cancer syndromes: Tools that can help connect the dots in primary care Emily Edelman, MS, CGC NCHPEG Cancer in the family: Primary Care Matters.
Colon polyps Peter Stanich, MD
Prof. Dr. Giuseppe Magazzu Prof. Dr. Dušanka Mičetić-Turk and all Progress of the Prospective study - Medicel.
HPI A 32 yo G2P2 woman presents to her PCP because of a lump that she felt on her lower belly. It is not painful but she thinks it has been growing in.
Transforming Clinical Practice Initiative (TCPI) An Overview Connie K
Evaluation Plan Steven Clauser, PhD Chief, Outcomes Research Branch Applied Research Program Division of Cancer Control and Population Sciences NCCCP Launch.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Pancreatic Cancer In 2012 there were 43,920 cases of pancreatic cancer. 10% of these cases have a family clustering of pancreatic cancers and associated.
European Laboratory for Food Induced Diseases (ELFID) University of Naples Federico II University of Naples Federico II Prof. Luigi Greco.
The management of low-risk basal cell carcinomas in the community Implementing NICE guidance in general practice May 2010 NICE guidance on cancer services.
Do you have 3 or more affected relatives? (2 or less)
Medical Advisory Board Quality assurance Maine Cancer Registry US Centers for Disease Control and Prevention Cancer Treatment Centers and Cancer Treating.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
GASTROINTESTINAL ENDOSCOPY Volume 78, No. 3 : 2013 F1 김태영
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Do we need colonoscopy in patients with gastric adenoma? The risk of colorectal adenoma in patients with gastric adenomas R3 Kim Jungwook Moon Hee Yang,
Colonoscopy: Coding, Quality and Cost Sharing
27th Annual Winter CME Conference
Irritable Bowel Syndrome
Polyposis Jodie Ouahed, MD Victor Fox, MD Boston Children’s Hospital
Genetic Counseling & Testing for Cancer Risk
Hereditary and Familial Colon Cancer
AAMC CCN Colorectal Cancer Screening Integrated Care Pathway
Noralane M Lindor  Clinical Gastroenterology and Hepatology 
Familial Colorectal Cancer, Beyond Lynch Syndrome
Supporting Patients With Colorectal Cancer
Other symptoms Jean Y Tang MD PhD Professor of Dermatology.
Presentation transcript:

Improving Outcomes in Hereditary Gastrointestinal Polyposis Syndromes in the Mediterranean Region Thomas M Attard MD FAAP FACG Associate Professor, Pediatrics, Gastroenterology, University of Malta, Malta. Consultant Gastroenterologist Children’s Mercy Hospital, Kansas MO, USA.

Content: Overview: Hereditary Gastrointestinal Polyposis Syndromes in Childhood and Adolescence Polyposis Burden in Children in the Mediterranean Basin Obstacles for Management of Childhood Polyposis Syndromes Pilot Project to Improve Outcomes in Children with Hereditary Gastrointestinal Polyposis Syndromes in the Medicel Forum

Genotypic and Phenotypic Heterogeneity in Hereditary Colorectal Cancer Syndromes. AC-I, Amsterdam Criteria I MMR, mismatch repair FAP, familial adenomatous polyposis AFAP, attenuated familial adenomatous polyposis; HBCC, hereditary breast and colorectal cancer PJS, Peutz–Jeghers syndrome FJP, familial juvenile polyposis CD, Cowden’s disease BRRS, Bannayan- Ruvalcaba–Riley syndrome. Lynch et al. Cancer 2004;100:53–64

Hereditary Gastrointestinal Cancer Syndromes in Childhood ~ 5% of individuals with colorectal cancer will have a recognizable hereditary gastrointestinal cancer predisposing syndrome Polyposis syndromes frequently present in the first two decades of life with intestinal / extraintestinal manifestations Management of hereditary polyposis syndromes includes genetic testing, screening and in many cases surgery during childhood / adolescence

Hereditary Cancer Syndromes that present in childhood / adolescence Familial Adenomatous Polyposis – (FAP 1:8,000) Peutz-Jeghers Syndrome – (PJS, 1:15,000) Juvenile Polyposis Syndrome – (JPS, 1:35 – 50,000) HNPCC PTEN Hamartoma Syndrome (Cowden’s Syndrome, BRRS) Hereditary Mixed Polyposis Syndrome HMPS MEN IIB MYH-Associated Polyposis (MAP)

Polyposis: Defining the syndrome (age) Polyp – Histology – Number – Distribution Associated Clinical features / findings Family History

Familial Adenomatous Polyposis Peutz-Jeghers Syndrome Juvenile Polyposis Syndrome PTEN- Hamartoma Syndrome Polyp distribution Colorectal, most will develop gastric, small intestinal Panintestinal (primarily small intestinal ) Colorectal, gastric Colorectal Polyp histology Panintestinal Adenomatous and (Gastric) fundic gland polyps Hamartomatous polyps ¥ψ Ψ a significant proportion of syndromic juvenile polyps will harbor areas of adenomatous transformation ¥ Peutz-Jeghers polyps have characteristic - prominent smooth muscle component in the submucosa Hereditary Cancer Syndromes – polyps by anatomic localization & histology

modified from Lynch HT, Attard TM, Gastroent. & Hepatology 2005 Hereditary Gastrointestinal Cancer Syndromes: Management FAPJPPJSPTEN – HS Before age 10 α Fetoprotein and abdominal ultrasound annually from birth to age 10years 10 – 20 years o Annual colonoscopy from age 10-12years  Colectomy when dx established o Annual upper endoscopy*, as soon as colonic polyps appear or 15 years in AFAP † o (no current consensus on thyroid screening but clinical examination and ultrasound of suspicious lesions needs to be part routine HCM visits) o Colonoscopy with polypectomy, annually if not all polyps removed, otherwise every 3 years from age 15 years o Upper endoscopy every 3 – 5 years from age 15 years; repeated annually if the patient is not polyp free o Annual clinical exam and baseline ultrasound of the thyroid from adolescence o Every 2-3 years, Upper endoscopy (EGD / EGD and enteroscopy), SBFT (? role of capsule endoscopy) o Annual testicular exam, ultrasound if clinically suspected o Every 2 year colonoscopy, upper endoscopy o SBFT (? enteroscopy) from age 15 years o Monthly breast self exam from age 18 years o Baseline thyroid US at age 18 years, annual neck exam

Hereditary colorectal Cancer Syndromes in the Mediterranean Basin Population specific data is lacking for most countries InSIGHT membership incl. Italy, Spain*, Israel, Serbia* Multiple observations on unique disease manifestations and natural history No significant participation in pediatric chemopreventive trials *Adult Gastroenterology Programs

PopulationChildren 0-14 FAP (1:8,000) FJP (1:50,000) PJS (1:60,000) ALBANIA ALGERIA , BOSNIA CROATIA EGYPT , FRANCE , GREECE ISRAEL ITALY LEBANON MALTA MOROCCO , SLOVENIA SPAIN TUNISIA TURKEY , ,2411,9581,632

Obstacles for Management of Childhood Polyposis Syndromes individually these are rare conditions → very different, complex management algorithms: – Genetic testing / Endoscopy / Surgery/ Chemoprevention / Surveillance need for team approach: – Gastroenterology / Surgery / Adult GI services / Genetic Counseling / Psychology changing / unclear management algorithms – access to research protocols / chemoprevention

Obstacles for Management Recognizing symptoms and family history at risk. Access and timely referral for comprehensive services Long term surveillance planning and follow-up including family screening Lack of medical guidelines / discrepancy in provider competence

Hereditary Gastrointestinal Polyposis Syndromes: Healthcare Provider Training Pediatric residents overall knowledge of gastrointestinal syndromes; proportion of correct answers by syndrome: pathogenesis and clinical features Variation in percent correct response rate by level of training FAPPJSJPPTEN - HS Attard TM et. al submitted J Cancer Edu. 2008

Hereditary Colorectal Cancer Registries National, institutional, regional entity that serves as repository of expertise and academic interest on the group of diseases Demonstrable patient benefit from belonging to a registry → earlier recognition and treatment Registries as the only resource able to liase and effect drug (egs. chemoprevention) trials Järvinen Hj et al. Gastroenterology May;118(5):

Informational / Educational Cooperation Coordination of Epidemiologic / Observational Studies Registry Based Family based recommendations Registry Based prospective Chemopreventive Studies STEPWISE MODEL OF THE DEVELOPMENT OF A REGIONAL HEREDITARY GASTROINTESTINAL CANCER REGISTRY

Step 1: Informational / Educational Cooperation Initial development of a network for individual case consultation Commitment toward timely, comprehensive – structured consultation Academic network to pool, study, publish interesting cases Identification – development of regional / national resources toward Step 2.

Step 1: Informational / Educational Cooperation Multidisciplinary team: – pediatric gastroenterologists + trainee (fellow) based in UoM (Malta, EU), Children’s Mercy Kansas City (MO, USA) – Genetic counselor – Psychologist based structured consultation with management plan De-identified clinical outline retained in dedicated database / Children’s Mercy Hospital, Kansas City (pending IRB approval)

Step 1: Informational / Educational Cooperation structured consultation: – Summary of salient clinical, endoscopic, +/- genetic testing findings – Outline of differential Dx, current diagnostic testing recommendations – Outline long term management incl. surveillance planning

Preparing for Step 2 and beyond How did step 1 go? Is there a perceived need for more structured resources? Are communication channels adequate? Does the model work? Coordinating epidemiologic and observational studies in regional heterogeneity of disease

Questions Acknowledgements